A circadian-like gene network programs the timing and dosage of heterochronic miRNA transcription during C. elegans development.
C. elegans
MS2 system
gene dosage
heterochronic
live imaging
microRNA
temporal patterning
transcriptional regulation
Journal
Developmental cell
ISSN: 1878-1551
Titre abrégé: Dev Cell
Pays: United States
ID NLM: 101120028
Informations de publication
Date de publication:
20 Nov 2023
20 Nov 2023
Historique:
received:
14
04
2023
revised:
10
07
2023
accepted:
02
08
2023
medline:
23
11
2023
pubmed:
30
8
2023
entrez:
29
8
2023
Statut:
ppublish
Résumé
Development relies on the exquisite control of both the timing and the levels of gene expression to achieve robust developmental transitions. How cis- and trans-acting factors control both aspects simultaneously is unclear. We show that transcriptional pulses of the temporal patterning microRNA (miRNA) lin-4 are generated by two nuclear hormone receptors (NHRs) in C. elegans, NHR-85 and NHR-23, whose mammalian orthologs, Rev-Erb and ROR, function in the circadian clock. Although Rev-Erb and ROR antagonize each other to control once-daily transcription in mammals, NHR-85/NHR-23 heterodimers bind cooperatively to lin-4 regulatory elements to induce a single pulse of expression during each larval stage. Each pulse's timing, amplitude, and duration are dictated by the phased expression of these NHRs and the C. elegans Period ortholog, LIN-42, that binds to and represses NHR-85. Therefore, during nematode temporal patterning, an evolutionary rewiring of circadian clock components couples the timing of gene expression to the control of transcriptional dosage.
Identifiants
pubmed: 37643611
pii: S1534-5807(23)00402-1
doi: 10.1016/j.devcel.2023.08.006
pii:
doi:
Substances chimiques
Caenorhabditis elegans Proteins
0
MicroRNAs
0
Receptors, Cytoplasmic and Nuclear
0
LIN-42 protein, C elegans
0
Transcription Factors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2563-2579.e8Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare no competing interests.